Position statement of expert panel of the Polish Allergology Society on the management of patients with bronchial asthma and allergic diseases during SARS-Cov-2 pandemics

IF 0.2 Q4 ALLERGY

Alergologia Polska - Polish Journal of Allergology Pub Date : 2020-03-01 DOI:10.5114/pja.2020.94606

M. Kowalski, Z. Bartuzi, A. Bręborowicz, M. Czarnecka-Operacz, J. Kruszewski, M. Kulus, M. Moniuszko, M. Niedoszytko, M. Nittner-Marszalska, R. Nowicki, B. Rogala, M. Chałubiński

{"title":"Position statement of expert panel of the Polish Allergology Society on the management of patients with bronchial asthma and allergic diseases during SARS-Cov-2 pandemics","authors":"M. Kowalski, Z. Bartuzi, A. Bręborowicz, M. Czarnecka-Operacz, J. Kruszewski, M. Kulus, M. Moniuszko, M. Niedoszytko, M. Nittner-Marszalska, R. Nowicki, B. Rogala, M. Chałubiński","doi":"10.5114/pja.2020.94606","DOIUrl":null,"url":null,"abstract":"The document prepared by the expert panel of allergy/immunology specialists representing Polish Allergy Society intends to provide allergists with recommendations with respect to proper management of allergic patients during SARS-CoV-2 pandemics Allergist should aim at reducing patient’s social interactions by replacing face-to-face visits with communication via telephone or internet In parallel allergist is responsible for assuring that the patient is receiving proper care of underlying allergic disease The experts panel provides eighteen recommendations for management of patients with asthma and allergic diseases during pandemics, indicating that in majority of patients asthma treatment (including inhaled corticosteroids) and allergy treatment should be continued Specific recommendations for treatment with allergen immunotherapy and with biologics are discussed in details","PeriodicalId":7469,"journal":{"name":"Alergologia Polska - Polish Journal of Allergology","volume":null,"pages":null},"PeriodicalIF":0.2000,"publicationDate":"2020-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.5114/pja.2020.94606","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Alergologia Polska - Polish Journal of Allergology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5114/pja.2020.94606","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"ALLERGY","Score":null,"Total":0}

引用次数: 2

Abstract

The document prepared by the expert panel of allergy/immunology specialists representing Polish Allergy Society intends to provide allergists with recommendations with respect to proper management of allergic patients during SARS-CoV-2 pandemics Allergist should aim at reducing patient’s social interactions by replacing face-to-face visits with communication via telephone or internet In parallel allergist is responsible for assuring that the patient is receiving proper care of underlying allergic disease The experts panel provides eighteen recommendations for management of patients with asthma and allergic diseases during pandemics, indicating that in majority of patients asthma treatment (including inhaled corticosteroids) and allergy treatment should be continued Specific recommendations for treatment with allergen immunotherapy and with biologics are discussed in details

查看原文本刊更多论文

波兰过敏学会专家小组关于严重急性呼吸系统综合征冠状病毒2型大流行期间支气管哮喘和过敏性疾病患者管理的立场声明

由代表波兰过敏学会的过敏/免疫学专家组成的专家小组编写的文件旨在为过敏专科医生提供关于SARS-CoV-2大流行期间过敏患者的适当管理的建议。过敏专科医生应以减少患者的社交互动为目标，通过电话或互联网交流取代面对面的就诊。同时，过敏专科医生有责任确保患者得到适当的潜在护理专家小组就大流行期间哮喘和过敏性疾病患者的管理提出了18项建议，表明大多数患者应继续接受哮喘治疗(包括吸入皮质类固醇)和过敏治疗，并详细讨论了用过敏原免疫疗法和生物制剂治疗的具体建议

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Alergologia Polska - Polish Journal of Allergology ALLERGY-

自引率

50.00%

发文量

期刊介绍： Alergologia Polska - Polish Journal of Allergology is aimed mainly at allergologists, but also medical doctors working in related fields, such as otolaryngology, pulmonology, and dermatology. The main goal of the journal is to ensure rapid publication of important research papers and interesting case studies from the following areas: allergology, diagnostics, therapy of allergic diseases, in particular in the area of immunotherapy, rhinitis, asthma. The Editorial Board accepts for publication original papers, case studies and letters to the Editor. We also publish review articles (both commissioned and those agreed upon with the Editor-in-Chief), articles dealing with standards of medical practice, as well as special issues. The journal is published quarterly. We guarantee short review times (up to two weeks) and immediate publication on-line upon Editor acceptance.